1. Home
  2. |Insights
  3. |"U.S. Healthcare Reform: What's in it for Biosimilars?" European Generics Medicines Association's 8th Annual Symposium on Biosimilars, London

"U.S. Healthcare Reform: What's in it for Biosimilars?" European Generics Medicines Association's 8th Annual Symposium on Biosimilars, London

Speaking Engagement | 09.09.10

Contacts

Insights

Speaking Engagement | 08.06.24

Data Privacy Fundamentals in the Age of AI

  • Speaking Engagement | 08.06.24

    HHS Final Rule Revising ACA Section 1557 Nondiscrimination Regulations: Significant Impact on Healthcare Providers

  • Speaking Engagement | 08.01.24

    SFIA's Supply Chain Disruptions, Due Diligence and Crisis Management

View All Insights